Myositis ossificans progressiva, right finger(s)
ICD-10 M61.144 is a billable code used to indicate a diagnosis of myositis ossificans progressiva, right finger(s).
Myositis ossificans progressiva (MOP) is a rare genetic disorder characterized by the abnormal formation of bone in muscles and connective tissues. This condition typically manifests after minor trauma or injury, leading to progressive ossification of soft tissues, particularly in the limbs. In the case of M61.144, the ossification is localized to the right finger(s), which can result in significant muscle weakness, stiffness, and restricted movement. Patients may experience pain and swelling in the affected area, and the condition can lead to functional impairment. The underlying pathophysiology involves mutations in the ACVR1 gene, which plays a crucial role in bone morphogenetic protein (BMP) signaling, leading to inappropriate bone formation. Diagnosis is often confirmed through imaging studies, such as X-rays or MRI, which reveal the presence of heterotopic ossification. Management typically focuses on symptomatic relief, physical therapy, and avoiding invasive procedures that may exacerbate the condition.
Detailed clinical notes on symptoms, physical examination findings, and imaging results.
Patients presenting with unexplained muscle stiffness and swelling after minor trauma.
Consideration of family history and genetic counseling may be necessary.
Surgical notes if any procedures are performed, along with pre-operative and post-operative assessments.
Patients requiring surgical intervention for severe functional impairment due to ossification.
Documentation of conservative management attempts before considering surgery.
Used for assessing functional limitations due to myositis ossificans progressiva.
Detailed evaluation notes and treatment plan.
Rheumatology or physical therapy specialists should document the impact on daily activities.
Myositis ossificans progressiva is a rare genetic disorder characterized by the abnormal formation of bone in muscles and connective tissues, often triggered by trauma.
Diagnosis is made through clinical evaluation, imaging studies, and sometimes genetic testing to confirm mutations in the ACVR1 gene.
